Category: Life Sciences
Global Life Sciences
-
Pipette Tips
... CAGR of 5.1% over the analysis period 2024-2030. Manual Pipette Tips, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$748.2 Million by the end of the ... Read More
-
Cardiac Arrhythmia Monitoring Devices
... 2030, growing at a CAGR of 5.4% over the analysis period 2024-2030. Resting ECG Devices, one of the segments analyzed in the report, is expected to record a 4.5% CAGR and reach US$4.9 Billion by ... Read More
-
Cardiopulmonary Autotransfusion Systems
... at a CAGR of 2.2% over the analysis period 2024-2030. On-Pump Transfusion Device, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$523.8 Million by the end ... Read More
-
Cell Dissociation
... CAGR of 11.6% over the analysis period 2024-2030. Enzymatic Dissociation Products, one of the segments analyzed in the report, is expected to record a 12.6% CAGR and reach US$506.9 Million by the end of the ... Read More
-
Cell Expansion
... CAGR of 14.8% over the analysis period 2024-2030. Cell Expansion Consumables, one of the segments analyzed in the report, is expected to record a 16.0% CAGR and reach US$42.4 Billion by the end of the ... Read More
-
Dengue Testing
... CAGR of 4.8% over the analysis period 2024-2030. ELISA-Based Tests, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$383.2 Million by the end of the analysis ... Read More
-
Diabetic Food
... CAGR of 4.8% over the analysis period 2024-2030. Dietary Beverages, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$6.2 Billion by the end of the analysis ... Read More
-
DNA and RNA Sample Preparation
... Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. DNA and RNA Sample Preparation Kits, one of the segments analyzed in the report, is expected to record a 4.5% CAGR ... Read More
-
Electric Submersible Pumps
... at a CAGR of 3.6% over the analysis period 2024-2030. On-Shore End-Use, one of the segments analyzed in the report, is expected to record a 3.9% CAGR and reach US$7.9 Billion by the end of ... Read More
-
Flushing Systems
... CAGR of 3.6% over the analysis period 2024-2030. Gravity Flush Systems, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$1.3 Billion by the end of the ... Read More
-
Food Grade Glycerin
... at a CAGR of 5.7% over the analysis period 2024-2030. Personal Care Application, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$937.1 Million by the end ... Read More
-
Glycerol
... 3.6% over the analysis period 2024-2030. Personal Care & Cosmetics End-Use, one of the segments analyzed in the report, is expected to record a 4.0% CAGR and reach US$1.4 Billion by the end of the ... Read More
-
Health Insurance
... CAGR of 5.9% over the analysis period 2024-2030. Private Service Provider, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.0 Trillion by the end of the ... Read More
-
Growth Factors (Blood and Tissue)
... Billion by 2030, growing at a CAGR of 8.5% over the analysis period 2024-2030. Interferons, one of the segments analyzed in the report, is expected to record a 10.1% CAGR and reach US$78.2 Billion by ... Read More
-
Machine Vision Systems
... at a CAGR of 4.1% over the analysis period 2024-2030. Machine Vision Hardware, one of the segments analyzed in the report, is expected to record a 3.7% CAGR and reach US$8.1 Billion by the end ... Read More
-
Adhesion Barriers
... CAGR of 6.6% over the analysis period 2024-2030. Synthetic Adhesion Barriers, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$825.4 Million by the end of the ... Read More
-
Analytical Laboratory Services
... at a CAGR of 9.0% over the analysis period 2024-2030. Bioanalytical Testing Services, one of the segments analyzed in the report, is expected to record a 9.5% CAGR and reach US$273.4 Million by the end ... Read More
-
Anesthesia Monitoring Devices
... at a CAGR of 8.4% over the analysis period 2024-2030. Advanced Anesthesia Monitors, one of the segments analyzed in the report, is expected to record a 9.1% CAGR and reach US$1.6 Billion by the end ... Read More
-
Animal Growth Promoters and Performance Enhancers
... reach US$24.5 Billion by 2030, growing at a CAGR of 4.1% over the analysis period 2024-2030. Non-Antibiotic Growth Promoters & Performance Enhancers, one of the segments analyzed in the report, is expected to record a ... Read More
-
Antimicrobial Textiles
... CAGR of 5.1% over the analysis period 2024-2030. Synthetic Organic Compounds, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$12.0 Billion by the end of the ... Read More
-
Artificial Joints
... CAGR of 4.4% over the analysis period 2024-2030. Cemented Joints, one of the segments analyzed in the report, is expected to record a 5.0% CAGR and reach US$21.2 Billion by the end of the analysis ... Read More
-
Aseptic Sampling
... CAGR of 10.1% over the analysis period 2024-2030. Manual Aseptic Sampling, one of the segments analyzed in the report, is expected to record a 11.0% CAGR and reach US$357.4 Million by the end of the ... Read More
-
Autoimmune Disease Diagnosis
... at a CAGR of 6.0% over the analysis period 2024-2030. Consumables & Assay Kits, one of the segments analyzed in the report, is expected to record a 6.4% CAGR and reach US$4.1 Billion by the ... Read More
-
Autoinjectors
... 15.9% over the analysis period 2024-2030. Rheumatoid Arthritis Therapy, one of the segments analyzed in the report, is expected to record a 15.8% CAGR and reach US$47.6 Billion by the end of the analysis period. ... Read More
-
Automotive Fabrics
... CAGR of 3.0% over the analysis period 2024-2030. Floor Covering Application, one of the segments analyzed in the report, is expected to record a 3.1% CAGR and reach US$10.8 Billion by the end of the ... Read More
Research Assistance
